Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. 1688AC025

R&D Systems™ Recombinant Human gAdiponectin/gAcrp30 Protein

Catalog No. 1688AC025
Change view
Click to view available options
Quantity:
25 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
1688AC025 25 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. 1688AC025 Supplier R&D Systems™ Supplier No. 1688AC025
Only null left
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human gAdiponectin/gAcrp30 Protein is derived from NS0. The Recombinant Human gAdiponectin/gAcrp30 Protein has been validated for the following applications: Bioactivity.

Specifications

Formulation Supplied as a 0.2μm filtered solution in PBS.
Gene ID (Entrez) 9370
Molecular Weight (g/mol) 16.7 kDa (monomer)
Name gAdiponectin/gAcrp30
Quantity 25 μg
Source Mouse myeloma cell line,NS0-derived human gAdiponectin/gAcrp30 protein Ala108-Asn244,with a C-terminal 6-His tag
Storage Requirements 4 months from date of receipt, 2 to 8° C as supplied.
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.